Nucelion Therapeutics, VeGen Bio Partner on CAR-T Therapy The Story: Nucelion Therapeutics and VeGen Bio have partnered to transfer technology and manufacture VL-2511, a Phase II dual-target CAR-T the...
ChrysCapital to Acquire Linux Laboratories Stake The Story: ChrysCapital is set to acquire a 20–25% stake in CNS-focused Linux Laboratories for around ₹600 crore, with Tata Capital Healthcare Fund II ...
